Graham T E
Department of Human Biology and Nutritional Sciences, University of Guelph Guelph, ON.
Can J Appl Physiol. 2001;26 Suppl:S103-19.
This paper addresses areas where there is controversy regarding caffeine as an ergogenic aid and also identifies topics that have not been adequately addressed. It is clear that caffeine, in moderate amounts, can be used orally as an ergogenic aid in aerobic activity lasting for more than 1 min. It increases endurance and speed, but not maximal VO2 and related parameters. While there are fewer well-controlled studies for resistance exercise, the literature would suggest similar improvements: increased endurance at submaximal tension and power generated in repeated contractions and no change in maximal ability to produce force. It is likely that theophylline (a related methylxanthine) has similar actions and it has been suggested that the combination of caffeine and sympathomimetics may be a more potent erogenic aid. The voids in our understanding of caffeine include the dose (what amount is optimal, what vehicle is used to deliver the drug as well as method, pattern, and mode of administration), the potential side effects (particularly in competitive settings), health implications (insulin resistance and if combined with ephedrine, cardiovascular risks) and mechanisms of action. It appears unlikely that increased fat oxidation and glycogen sparing is the prime ergogenic mechanism.
本文探讨了关于咖啡因作为一种促力剂存在争议的领域,并确定了尚未得到充分探讨的主题。显然,适量的咖啡因可口服作为持续超过1分钟的有氧运动的促力剂。它能提高耐力和速度,但不会提高最大摄氧量及相关参数。虽然针对抗阻运动的严格对照研究较少,但文献表明有类似的改善效果:在次最大张力下耐力增加,重复收缩时产生的力量增加,而最大发力能力不变。茶碱(一种相关的甲基黄嘌呤)可能有类似作用,有人认为咖啡因与拟交感神经药的组合可能是一种更有效的促力剂。我们对咖啡因的认识空白包括剂量(何种剂量最佳、使用何种载体给药以及给药方法、模式和方式)、潜在副作用(特别是在竞技环境中)、对健康的影响(胰岛素抵抗以及与麻黄碱合用时的心血管风险)和作用机制。脂肪氧化增加和糖原节省似乎不太可能是主要促力机制。